| Course | PA 514 Comprehensive Clinical Module Infectious Disease |
|---|---|
| Week | 4 |
| Paper type | Empiric coverage rationale |
| Length | About 810 words, 5 pages |
| Format | APA 7 student paper |
| School | Chamberlain University |
| Program | Master of Physician Assistant Studies (MPAS) |
| Updated | October 2026 |
Free sample paper for PA 514 Week 4
Empiric Coverage Rationale at 11:10 p.m. on Thursday: Ceftriaxone Plus Ampicillin for R.A., Aimed Candidate by Candidate, With Campylobacter and Shiga Toxin Deliberately Left Uncovered
Student Name
Chamberlain University
PA 514: Comprehensive Clinical Module Infectious Disease
Instructor Name
Month Day, Year
Empiric Coverage Rationale at 11:10 p.m. on Thursday: Ceftriaxone Plus Ampicillin for R.A., Aimed Candidate by Candidate, With Campylobacter and Shiga Toxin Deliberately Left Uncovered
What Time It Is
Thursday, April 9, 11:10 p.m., half an hour after R.A. reached the emergency department. Both blood culture sets went to the laboratory at 10:50 p.m. A stool sample has not yet been produced. No culture, Gram stain or stool result exists. Everything below is reasoned from the history, the examination and the first blood tests.
Findings at this hour: a fever of 39.4 C and a pulse of 112, with systolic pressure in the high 90s that climbed only to 108 after a liter of saline, abdomen soft and diffusely tender without guarding; white cells 13.8 × 10^9/L; serum creatinine 1.4, against 0.8 at last year's rheumatology check. Diarrhea is watery, not bloody, six to eight times a day.
The Candidates That Survived
Four candidates remain after last week's timing analysis, each still tied to its exposure and interval.
Nontyphoidal Salmonella, from daily chick handling and the tote cleaning thirty hours before onset, inside its 6 to 72 hour window.
Campylobacter, from the cabin well water three to four days before onset, inside its 1 to 10 day window.
Shiga toxin-producing E. coli, from the same water, inside its 2 to 10 day window.
Listeria monocytogenes, from deli turkey three to five days before onset, inside its bacteremia window.
The Gap, Written Down
Not known at this hour: whether any organism is in the blood; which organism is in the stool; whether Shiga toxin is present. The stool panel, once a sample is obtained, will return in about twelve hours; blood cultures, if positive, will usually flag within one to two days. The decision is whether to start antibiotics before those results.
Treatment is warranted now. R.A. is febrile, tachycardic with low blood pressure that responded only partly to fluid and is taking methotrexate. The IDSA diarrhea guideline does not recommend empiric antibiotics for most acute watery diarrhea, but makes an exception for people who are immunocompromised, and recommends that blood cultures be obtained in people with signs of sepsis or immunocompromise (Shane et al., 2017). Both conditions apply.
Aimed, Candidate by Candidate
Salmonella: ceftriaxone 2 g intravenously every 24 hours. Ceftriaxone is among the agents the guideline lists for nontyphoidal Salmonella in groups at risk of invasive disease, including people with immunosuppression (Shane et al., 2017). Ciprofloxacin was not chosen because fluoroquinolone resistance in Salmonella has made reduced susceptibility common enough to matter in a patient this ill.
Listeria: ampicillin 2 g intravenously every 4 hours. Cephalosporins, including ceftriaxone, do not treat Listeria, so ceftriaxone alone would leave the most dangerous candidate uncovered in an immunosuppressed host.
What Was Left Uncovered
Campylobacter is not reliably covered by ceftriaxone, and azithromycin was not added. Campylobacter rarely enters the bloodstream, its illness is usually self-limited, and the stool panel will report within hours; if it is positive, azithromycin can be added then. Shiga toxin-producing E. coli was deliberately left uncovered, because antibiotics are generally avoided in STEC infection given concern about hemolytic uremic syndrome, and the nonbloody diarrhea makes STEC less likely. Each gap is accepted for a stated reason and has a result that will close it.
Methotrexate at This Hour
Methotrexate is held during the acute infection, and the rising creatinine is noted, because methotrexate is cleared by the kidneys and reduced clearance increases its toxicity. Trimethoprim-sulfamethoxazole is avoided as an empiric choice for the same reason: combined with methotrexate it is associated with cytopenias (Bourré-Tessier & Haraoui, 2010).
Other Explanations Kept in View
Not every febrile diarrheal illness with a low blood pressure is an enteric infection. Clostridioides difficile was considered and judged unlikely, since R.A. had taken no antibiotics in the previous three months and had not been in hospital. An inflammatory flare of bowel disease was considered and set aside because R.A. has no such history. And because methotrexate can itself cause mucositis and diarrhea at toxic levels, a methotrexate level was not sent, but the dose history was checked and showed no recent change or double dosing. These alternatives are recorded so a reader can see the infectious plan was chosen with them in mind.
What Would Change This Plan
A stool panel positive for Shiga toxin would raise a question about stopping antibiotics. A blood culture growing a gram-negative rod would leave ceftriaxone in place and make ampicillin less likely to be needed. A blood culture growing gram-positive rods would point to Listeria and keep ampicillin as the main drug.
References
Bourré-Tessier, J., & Haraoui, B. (2010). Methotrexate drug interactions in the treatment of rheumatoid arthritis: A systematic review. The Journal of Rheumatology, 37(7), 1416-1421. https://doi.org/10.3899/jrheum.090153
Shane, A. L., Mody, R. K., Crump, J. A., Tarr, P. I., Steiner, T. S., Kotloff, K., Langley, J. M., Wanke, C., Warren, C. A., Cheng, A. C., Cantey, J., & Pickering, L. K. (2017). 2017 Infectious Diseases Society of America clinical practice guidelines for the diagnosis and management of infectious diarrhea. Clinical Infectious Diseases, 65(12), e45-e80. https://doi.org/10.1093/cid/cix669
PA 514 Week 4 instructions, in plain terms
The fourth week asks you to justify an empiric antibiotic plan at a defined moment in the case. State the time and list only what was known then, including vital signs, examination and first laboratory results, so the reasoning cannot borrow from later results. Carry forward the candidates that survived your timing analysis. Explain whether treatment should start before results return, and cite guidance on when antibiotics are and are not recommended for this syndrome. Then match each drug, with dose, route and interval, to the specific organism it targets. Name any candidate you have chosen not to cover and give the reason. Address host factors and drug interactions that shape the choice. Consider other explanations for the presentation. End with the results that would prompt you to add, stop or narrow therapy.
How the PA 514 Week 4 example is put together
The paper opens at 11:10 p.m. on April 9 with blood cultures drawn twenty minutes earlier and no stool sample yet. It lists the fever, pulse, partial response to a liter of saline, leukocytosis and a creatinine of 1.4. Four candidates are restated with their exposures. A gap section cites the IDSA infectious diarrhea guideline to show why an immunocompromised, septic-looking patient is the exception to withholding antibiotics. Ceftriaxone 2 g daily is aimed at Salmonella and ampicillin 2 g every four hours at Listeria, with the reason ceftriaxone alone fails for Listeria. A section on what was left uncovered explains the choices on Campylobacter and STEC. Methotrexate is held and trimethoprim-sulfamethoxazole avoided with a citation on cytopenias. C. difficile, inflammatory bowel disease and methotrexate toxicity are each weighed, and the close lists three results that would change the plan.
Where the points sit in the PA 514 Week 4 rubric
The heaviest weight in this rationale falls on matching drugs to organisms: a regimen that is defensible but never tied to specific candidates earns little. Faculty next check the timing discipline, so citing a culture result that did not exist yet at the chosen hour is a major deduction. A strong share goes to justifying treatment at all, with guidance cited for when empiric antibiotics are appropriate in diarrheal illness. Explicit gaps carry real credit, since leaving an organism uncovered with a reason shows judgment, while silent omissions suggest error. Points are lost for ignoring an interacting drug or a kidney value already on the chart. The final section is marked on whether it names results that would change the regimen. Dose, route and frequency must be stated for each agent.
PA 514 Week 4 help: mistakes that cost points
Many drafts of this rationale lose points by listing broad-spectrum drugs without saying which organism each one is for. If you send your case, the time your prompt fixes and your surviving candidates, the model plan will build the plan around those candidates and the findings available at that hour. It cites the guideline your course uses on empiric therapy and works your patient's host factors, kidney function and current medicines into the drug choice. Organisms deliberately left uncovered are named with their reasons and the result that would close each gap. If your instructor expects a particular format, such as a table of drug against target, the sample follows it. Doses should be checked against your program's drug reference before you use any of the reasoning.
Get a PA-514 Week 4 example written to your instructions
Send the Week 4 instructions and the case your section issued, and a custom example is written to them and returned inside 24 to 48 hours, with the candidate list, the stated gap and the pending result all in place. The first one is free. If a heading order or template was supplied, the example follows it exactly.
More PA 514 papers and MPAS samples
- PA 514 Week 1: Exposure-First Discussion Post
- PA 514 Week 2: Exposure History Timeline
- PA 514 Week 3: Incubation Window Analysis
- PA 514 Week 5: Culture Narrowing Memo
- PA 514 Week 6: Antibiogram Reading Exercise
- PA 514 Week 7: Stop Date Justification
- PA 514 Week 8: Reportable Condition Brief
- PA 512 Week 4: Anemia Indices Worksheet
- PA 510 Week 4: Clinical Photograph Critique
- PA 505 Week 4: Criteria Application Exercise
- PA 504 Week 4: Review of Systems Draft
PA 514 Week 4 questions, answered
Is the paper wrong if the result later contradicts the coverage?
Not by itself. This week is marked on the quality of an argument made under a stated gap, so a rationale that was reasonable on the information available can score well even where the organism turned out to be something else. What does cost points is a paper that hides the gap, or one written as though the answer had already arrived.
Does the rationale have to name specific agents?
Sections differ, and several keep it at the level of the organisms to be reached rather than at named products, since the reasoning is what carries the points. Where agents are asked for, each one is expected to sit beside the candidate it is there for, and a name appearing with no candidate attached is where the deduction lands.
Where does the stopping date belong?
Not here, in most sections. Week 4 is scored on a decision made with no result in hand, and length of therapy is set as its own assignment later in the term, which is why a rationale crowded with a duration often reads as answering two questions at once. A line saying when a result is expected is a different thing and does belong.
Where can I find a free PA 514 Week 4 sample paper?
This page holds the full PA 514 Week 4 empiric coverage rationale, ceftriaxone plus ampicillin aimed candidate by candidate, written as of 11:10 p.m. before any result.
Why does the PA 514 Week 4 sample add ampicillin to ceftriaxone?
Cephalosporins do not treat Listeria, and the patient's methotrexate and recent deli meat keep invasive listeriosis on the list.